Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury
Status:
Recruiting
Trial end date:
2024-01-31
Target enrollment:
Participant gender:
Summary
A multi-center, prospective, open-label, controlled study of the pharmacokinetics and safety
of the LicartTM topical system in pediatric and adult participants with minor soft tissue
injuries. 150 male and female participants aged 6-16 and 18-45 with soft tissue injuries
meeting the following criteria will be enrolled to evaluate the pharmacokinetics and safety
of the Licart topical system in pediatric and adult participants with minor soft tissue
injuries over a 14-day treatment course. The analgesic effects will also be evaluated of the
topical system in pediatric and adult participants with minor soft tissue injuries over a
14-day treatment course. To collect principal investigator-reported global response to
therapy.